NEOG vs. ABBV
NEOG (Neogen Corporation) and ABBV (AbbVie Inc.) are both stocks. Both are in the Healthcare sector — NEOG in Diagnostics & Research, ABBV in Drug Manufacturers - General. Over the past 10 years, NEOG returned -7.64%/yr vs 19.47%/yr for ABBV. At a 0.27 correlation, their price movements are largely independent.
Performance
NEOG vs. ABBV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NEOG achieves a 26.32% return, which is significantly higher than ABBV's 4.43% return. Over the past 10 years, NEOG has underperformed ABBV with an annualized return of -7.64%, while ABBV has yielded a comparatively higher 19.47% annualized return.
NEOG
- 1D
- -1.01%
- 1M
- -0.79%
- YTD
- 26.32%
- 6M
- 23.50%
- 1Y
- 85.12%
- 3Y*
- -25.89%
- 5Y*
- -28.05%
- 10Y*
- -7.64%
ABBV
- 1D
- 2.07%
- 1M
- 8.84%
- YTD
- 4.43%
- 6M
- 4.29%
- 1Y
- 31.92%
- 3Y*
- 24.36%
- 5Y*
- 19.80%
- 10Y*
- 19.47%
NEOG vs. ABBV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NEOG Neogen Corporation | 26.32% | -42.42% | -39.63% | 32.04% | -66.46% | 14.53% | 21.51% | 14.49% | -7.55% | 24.56% |
ABBV AbbVie Inc. | 4.43% | 33.08% | 18.86% | -0.23% | 24.01% | 32.43% | 27.72% | 1.47% | -0.96% | 60.07% |
Correlation
The correlation between NEOG and ABBV is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.07 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.17 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.23 |
Correlation (All Time) Calculated using the full available price history since Jan 2, 2013 | 0.27 |
Over the past year, the correlation between NEOG and ABBV has dropped to 0.07 - well below their long-term average of 0.27, suggesting their price drivers have been diverging.
Fundamentals
NEOG:
$1.92B
ABBV:
$416.46B
NEOG:
-$2.80
ABBV:
$2.05
NEOG:
2.20
ABBV:
6.63
NEOG:
0.91
ABBV:
15.14
NEOG:
$870.54M
ABBV:
$62.82B
NEOG:
$346.99M
ABBV:
$46.15B
NEOG:
-$474.40M
ABBV:
$17.96B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NEOG vs. ABBV — Risk / Return Rank
NEOG
ABBV
NEOG vs. ABBV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Neogen Corporation (NEOG) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NEOG | ABBV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.20 | ||
| Sortino ratioReturn per unit of downside risk | +0.47 | ||
| Omega ratioGain probability vs. loss probability | 1.30 | 1.24 | +0.07 |
| Calmar ratioReturn relative to maximum drawdown | 3.09 | 1.85 | +1.24 |
| Martin ratioReturn relative to average drawdown | 7.00 | 4.11 | +2.88 |
Loading charts...
Drawdowns
NEOG vs. ABBV - Drawdown Comparison
The maximum NEOG drawdown since its inception was -90.92%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for NEOG and ABBV.
Loading charts...
Drawdown Indicators
| NEOG | ABBV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -90.92% | -45.09% | -45.83% |
Max Drawdown (1Y)Largest decline over 1 year | -27.71% | -17.32% | -10.39% |
Max Drawdown (3Y)Largest decline over 3 years | -81.59% | -20.74% | -60.85% |
Max Drawdown (5Y)Largest decline over 5 years | -90.59% | -21.92% | -68.67% |
Max Drawdown (10Y)Largest decline over 10 years | -90.92% | -45.09% | -45.83% |
Current DrawdownCurrent decline from peak | -81.73% | -1.66% | -80.07% |
Average DrawdownAverage peak-to-trough decline | -26.95% | -10.70% | -16.25% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.20% | 7.78% | +4.42% |
Volatility
NEOG vs. ABBV - Volatility Comparison
Neogen Corporation (NEOG) has a higher volatility of 11.10% compared to AbbVie Inc. (ABBV) at 9.26%. This indicates that NEOG's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NEOG | ABBV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.10% | 9.26% | +1.84% |
Volatility (6M)Calculated over the trailing 6-month period | 40.19% | 19.11% | +21.08% |
Volatility (1Y)Calculated over the trailing 1-year period | 58.44% | 25.23% | +33.21% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 48.97% | 23.12% | +25.85% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 41.56% | 25.83% | +15.73% |
Dividends
NEOG vs. ABBV - Dividend Comparison
NEOG has not paid dividends to shareholders, while ABBV's dividend yield for the trailing twelve months is around 2.87%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 2.87% | 2.87% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% |
NEOG Neogen Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
NEOG vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between Neogen Corporation and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NEOG vs. ABBV - Profitability Comparison
NEOG - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Neogen Corporation reported a gross profit of 99.00M and revenue of 211.20M. Therefore, the gross margin over that period was 46.9%.
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a gross profit of 12.53B and revenue of 15.00B. Therefore, the gross margin over that period was 83.5%.
NEOG - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Neogen Corporation reported an operating income of -3.30M and revenue of 211.20M, resulting in an operating margin of -1.6%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported an operating income of 4.73B and revenue of 15.00B, resulting in an operating margin of 31.6%.
NEOG - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Neogen Corporation reported a net income of -17.00M and revenue of 211.20M, resulting in a net margin of -8.1%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AbbVie Inc. reported a net income of 699.00M and revenue of 15.00B, resulting in a net margin of 4.7%.
Frequently Asked Questions
NEOG and ABBV have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NEOG has higher volatility (11.10%) compared to ABBV (9.26%). In terms of maximum drawdown, NEOG dropped -90.92% vs ABBV's -45.09%.
NEOG currently has the higher Sharpe Ratio (1.47 vs 1.27), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NEOG and ABBV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer